- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04657601
Prospective Study of a New Endolumenal Device Used During Endoscopic Polypectomy in the Colon (DiLumenC2)
Prospective Evaluation Utilizing an Endolumenal Interventional Platform Device to Facilitate Endoscopic Polypectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a prospective, post-market evaluation of the performance of the DiLumen C2 Endolumenal Interventional Platform ("C2 device") used as an endoscopic dual balloon accessory device used to ensure complete positioning, visualization, and diagnosis in endoscopic treatments in the large intestine. The DiLumen Endolumenal Interventional Knife ("IK device") and the DiLumen Endolumenal Interventional Grasper ("IG device") are disposable instruments used with the C2 device. These devices are cleared by the US Food and Drug Administration (FDA) for commercial use in endolumenal therapies and will be used on-label in this study. The overall goal of this study is to evaluate the clinical performance of the C2 device and its related instruments. Intra-procedure parameters (procedure timepoints, anesthesia use, polyp location and description), final pathology/histology, and general complications will also be evaluated. Investigators will also be asked to assess the ease of use of the C2Interventional Platform.
To accomplish this goal, up to 100 subjects will be enrolled at up to 5 clinical sites and treated using the C2 device and related instruments. Evaluations will be performed pre-procedure, during the procedure, and at discharge. Assessments will include polyp classification/pathology, procedure timepoints, final pathology/histology, adverse events, and ease of use. As per the FDA cleared product labeling this study will be limited to subjects undergoing an endoscopic procedure to remove polyps in the large intestine.
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Men or women 18-85 years of age.
- Have the ability to understand the requirements of the study, to provide written informed consent, and to comply with the study protocol.
- Scheduled for endoscopic removal of suspected colorectal adenomatous polyps which are sessile or polypoid lesions.
- Have, in the opinion of the Investigator(s) or co-investigator(s), no medical contraindication to endoscopic submucosal dissection (ESD).
Exclusion Criteria:
- Have a contraindication to colonoscopy, including but not limited to active colitis, diverticulitis, perforation, or stricture.
- Have a history of open or laparoscopic colorectal surgery.
- Have a history of Inflammatory Bowel Disease (IBD).
- Have a suspected invasive malignancy on polyp assessment.
- Any medical or surgical condition that would preclude the potential benefit ESD.
- Any case where the device or instrument would be too large or too small to achieve a successful result.
- Anatomy or other factors that prohibit safe access to the large intestine such as previous radiation therapy to the affected area.
- History of AIDS, HIV, or active hepatitis.
- History of mental illness, including psychological or neurological conditions (addiction to substances such as alcohol. e.g.) that in the investigator's opinion would pre-empt their ability or willingness to participate in the study.
- Has cardiopulmonary conditions that present prohibitive anesthesia risk.
- Has uncorrectable coagulopathy or hemorrhagic diathesis.
- Has an active infection or fever.
- Has allergy to any component of the treatment procedure.
- Patients who are pregnant.
- Pediatric case (Age < 18 years)
- Any case in which use of the DiLumen C2 device is not needed.
- Any case not described in the indications.
- Currently involved in another investigational product for similar purposes.
- Prisoners.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Treatment Group
Patients undergo polypectomy facilitated by the study device.
|
Dual balloon accessory to an endoscope and related instruments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The ability of the investigator to perform an endoscopic ESD safely and effectively
Time Frame: Through study completion, up to 7 days
|
Whether or not the polyp was removed and if there were any adverse events
|
Through study completion, up to 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Details of the procedure
Time Frame: Through study completion, up to 7 days
|
Procedure time
|
Through study completion, up to 7 days
|
Details of the procedure
Time Frame: Through study completion, up to 7 days
|
Dissection speed
|
Through study completion, up to 7 days
|
Legnth of Hospital Stay
Time Frame: Through study completion, up to 7 days
|
How long the patient was in the hospital following the polypectomy
|
Through study completion, up to 7 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- USLUM 1802 or 2020-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polyps of Colon
-
Centre Hospitalier Departemental VendeeTerminated
-
Hôpital Edouard HerriotCompleted
-
University College, LondonNot yet recruitingPolyps | Colon Polyp | Adenoma Colon | Colorectal Polyp | Polyps of ColonUnited Kingdom
-
Centre hospitalier de l'Université de Montréal...Pentax MedicalCompletedColo-rectal Cancer | Polyps of ColonCanada
-
Carponovum ABThe First Affiliated Hospital of Xiamen UniversityCompleted
-
Michael WallaceOlympus America, Inc.CompletedPost-endoscopic Mucosal Resection of Colon PolypsUnited States
-
Asian Institute of Gastroenterology, IndiaRecruitingPolyps | Polyps of Colon | Polyp IntestineIndia
-
Radboud University Medical CenterCatharina Ziekenhuis Eindhoven; Maasstad Hospital; Evangelisches Krankenhaus... and other collaboratorsRecruitingPolyps of Colon | Recurrence, Local NeoplasmNetherlands
-
Lumendi, LLCUnknown
-
Baylor College of MedicineTerminatedAdenomatous Polyp of ColonUnited States
Clinical Trials on DiLumen C2 Endolumenal Interventional Platform
-
Lumendi, LLCWeill Medical College of Cornell UniversityCompleted
-
Mercy Medical CenterCompletedColonic PolypUnited States